RECOVER-AUTONOMIC Platform Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

July 9, 2025

Study Completion Date

July 9, 2025

Conditions
Long COVIDLong Covid19Long Covid-19
Interventions
DRUG

IVIG + Coordinated Care

Participants will receive IVIG for a duration of 9 months and coordinated non-pharmacologic care for a duration of 3 months, concurrent with IVIG administration. Coordinated non-pharmacologic care involves volume expansion through high salt diet, water intake, abdominal binder, exercise/rehabilitation, motivation, education, and assisted care through a care coordinator.

DRUG

IVIG Placebo + Coordinated Care

"Normal saline given intravenously will be the control (placebo) product. Blinding IV bag and tubing covers will be used for both IVIG and Placebo administration.~Participants will receive IVIG placebo for a duration of 9 months and coordinated non-pharmacologic care for a duration of 3 months, concurrent with IVIG placebo administration. Coordinated non-pharmacologic care involves volume expansion through high salt diet, water intake, abdominal binder, exercise/rehabilitation, motivation, education, and assisted care through a care coordinator."

DRUG

Ivabradine + Coordinated Care

Participants will receive Ivabradine for a duration of 3 months and coordinated non-pharmacologic care for a duration of 3 months, concurrent with ivabradine administration. Coordinated non-pharmacologic care involves volume expansion through high salt diet, water intake, abdominal binder, exercise/rehabilitation, motivation, education, and assisted care through care coordinator.

DRUG

Ivabradine Placebo + Coordinated Care

"The control (placebo) oral tablets will be similar to the study drug, ivabradine.~The control packaging matches the packaging.~Participants will receive Ivabradine placebo for a duration of 3 months and coordinated non-pharmacologic care for a duration of 3 months, concurrent with ivabradine placebo administration. Coordinated non-pharmacologic care involves volume expansion through high salt diet, water intake, abdominal binder, exercise/rehabilitation, feedback, nutrition counseling, motivation, education, and assisted care through care coordinator."

DRUG

IVIG + Usual Care

Participants will receive IVIG for a duration of 9 months and usual non-pharmacologic care (control) for a duration of 3 months. This will be concurrent with scheduled IVIG administration.

DRUG

IVIG Placebo + Usual Care

"Normal saline given intravenously will be the control (placebo) product. The normal saline will be of similar formulation and appearance to IVIG.~Participants will receive IVIG placebo for a duration of 9 months and usual non-pharmacologic care (control) for a duration of 3 months. This will be concurrent with scheduled IVIG placebo administration."

DRUG

Ivabradine + Usual Care

Participants will receive Ivabradine for a duration of 3 months and usual non-pharmacologic care (control) for a duration of 3 months, concurrent with ivabradine administration.

DRUG

Ivabradine Placebo + Usual Care

"The control (placebo) oral tablets will be similar to the study drug, ivabradine.~The control packaging matches the packaging.~Participants will receive Ivabradine placebo for a duration of 3 months and usual non-pharmacologic care (control) for a duration of 3 months, concurrent with ivabradine placebo administration."

Trial Locations (50)

10032

Columbia University Irving Medical Center - Appendix A & B, New York

10467

Montefiore Medical Center - Moses Campus - Appendix B, The Bronx

11794

Stony Brook University Hospital - Appendix A & B, Stony Brook

13617

St. Lawrence Health Medical Campus - Appendix A & B, Canton

14203

University at Buffalo - Appendix A & B, Buffalo

20010

MedStar National Rehabilitation Hospital - Appendix B only, Washington D.C.

21287

Johns Hopkins Hospital - Appendix A Only, Baltimore

22908

University of Virginia Health System, University Hospital - Appendix A & B, Charlottesville

23507

Sentara Norfolk General Hospital - Appendix A & B, Norfolk

25701

Marshall Health - University Physicians and Surgeons - Appendix A & B, Huntington

27710

Duke University Hospital - Appendix A & B, Durham

27834

East Carolina University - Appendix B Only, Greenville

30303

Grady Memorial Hospital - Woodruff Memorial Research - Appendix A & B, Atlanta

30310

Morehouse School of Medicine - Appendix A & B, Atlanta

32610

University of Florida Health - Appendix A & B, Gainesville

33157

Innovation Clinical Trials Inc.- Appendix A & B, Palmetto Bay

33805

Lakeland Regional Medical Center - Appendix A & B, Lakeland

36801

East Alabama Medical Center - Appendix B Only, Opelika

37232

Vanderbilt University Medical Center, Nashville

39216

University of Mississippi Medical Center - Appendix A & B, Jackson

40536

University of Kentucky Medical Center - Appendix A & B, Lexington

44195

Cleveland Clinic - Appendix A & B, Cleveland

48202

Henry Ford Hospital - Appendix A & B, Detroit

52242

University of Iowa - Appendix A & B, Iowa City

55905

Mayo Clinic - Appendix A & B, Rochester

60201

NorthShore University HealthSystem - Evanston Hospital - Appendix B Only, Evanston

60612

Rush University Medical Center - Appendix B Only, Chicago

University of Illinois at Chicago - Appendix A & B, Chicago

63110

Washington University School of Medicine - Appendix B Only, St Louis

66205

University of Kansas Medical Center CTSU Fairway - Appendix A & B, Fairway

70112

University Medical Center New Orleans - Appendix A & B, New Orleans

72205

University of Arkansas for Medical Sciences - Appendix A & B, Little Rock

73104

University of Oklahoma Health Science Center - Oklahoma Clinical and Translational Science Institute - Appendix A & B, Oklahoma City

75235

Southwest Family Medicine Associates - Appendix A & B, Dallas

78229

University of Texas Health Science Center at San Antonio - Appendix A & B, San Antonio

78701

University of Texas Health Science Center at Houston, Houston

78759

National Neuromuscular Research Institute - Appendix A & B, Austin

80045

University of Colorado Anschutz Medical Campus Clinical and Translational Research Center (CTRC) - Appendix A & B, Aurora

84102

Bateman Horne Center - Appendix B Only, Salt Lake City

85006

Center for Complex Neurology - Appendix A & B, Phoenix

90048

Cedars Sinai Medical Center - Appendix A & B, Los Angeles

92307

University of California San Diego - Appendix B Only, La Jolla

94305

Stanford University - Appendix B Only, Stanford

96813

Queens Medical Center - Appendix B Only, Honolulu

97239

Oregon Health and Science University - Appendix A & B, Portland

98034

Evergreen Hospital Medical Center - Appendix A & B, Kirkland

99204

Providence Medical Research Center - Appendix A & B, Spokane

02115

Brigham and Women's Hospital - Appendix A Only, Boston

02860

Kent Hospital - Appendix A & B, Pawtucket

05405

Vermont Lung Center, University of Vermont - Appendix B Only, Burlington

All Listed Sponsors
lead

Kanecia Obie Zimmerman

OTHER

NCT06305780 - RECOVER-AUTONOMIC Platform Protocol | Biotech Hunter | Biotech Hunter